Contact Person
    Nicole Mastrell

    Event Manager & PA to CEO
    Phone: (M) +45 6141 8634 Linkedin

    Talks at the Square: Mathias Uhlen – Experience from a serial entrepreneur

    Mathias Uhlen, Professor from KTH Royal Institute of Technology in Stockholm, will visit BioInnovation Institute to give a talk on his experience on being a serial entrepreneur.

    At the event Mathias will talk about the knowledge he has acquired through his long and esteemed career as both an academic and an entrepreneur. Mathias has more than 600 peer-reviewed publications and more than 70 international patent applications. He has founded 15 biotech start-up companies, and he has been member of many Board of Directors, including international public companies, such as Bure Equity (Sweden), Novozymes (Denmark), Nordiag (Norway) and Amersham (UK).

    Date: Tuesday, April 23, 2019
    Time: 9:30 – 11:45
    Venue: BioInnovation Institute, Ole Maaløes Vej 3, 2200 Copenhagen


    Please note, that the event has free admittance with 100 tickets available. Please sign up quickly to secure your seat.



    Doors open


    Mathias Uhlen: Experience from a serial entrepreneur – 15 biotech start-ups later…


    Fireside chat: Mathias Uhlen & Jens Nielsen, CEO of BioInnovation Institute


    Q&A session


    Informal networking and closing reception

    About Mathias Uhlen

    Mathias Uhlen is a professor at the Royal Institute of Technology (KTH), guest professor at the Karolinska Institutet and part-time professor at the Danish Technical University (DTU). His research is focused on protein science, antibody engineering and precision medicine and ranges from basic research to more applied research, including clinical applications in cancer, cardiovascular diseases, autoimmune diseases and neurobiology.

    Since 2003, he has led an international effort to create the Human Protein Atlas and he recently initiated the SCAPIS SciLifeLab Wellness Profiling project in which individuals are followed by repeated analysis every third months with omics-based analysis. Uhlen’s research has resulted in more than 600 publications with a current h-index of 115 (Google Scholar). He is member of the National Academy of Engineering (NAE) in USA, the Royal Swedish Academy of Science (KVA), the Swedish Academy of Engineering Science (IVA) and the European Molecular Biology Organization (EMBO). He was, starting in 2010, the founding Director of the Science for Life Laboratory (SciLifeLab), a national center for molecular bioscience.